Colgate-Palmolive Company

(New York Stock Exchange)
Bullish +62

Colgate-Palmolive Company (NYSE:CL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

πŸ“ˆ Colgate-Palmolive reported quarterly EPS of $0.99, beating the consensus estimate of $0.95.

πŸ’° Revenue grew 4.9% year-over-year to reach $5.36 billion in the latest quarter.

🏦 The stock holds a consensus 'Moderate Buy' rating from nineteen brokerages with an average 12-month price target of $99.

πŸ“‰ Piper Sandler raised its price target to $96.00 and upgraded the rating to 'overweight'.

πŸ“ˆ Deutsche Bank restated a 'buy' rating with a higher price target of $101.00.

πŸ“‰ JPMorgan Chase lowered its price target from $104.00 to $103.00 while maintaining an 'overweight' rating.

πŸ’Έ The company pays a quarterly dividend of $0.53, resulting in a 2.4% annualized yield.

⚠️ The dividend payout ratio is relatively high at 84.13%, indicating a significant portion of earnings are distributed.

πŸ“‰ COO Panagiotis Tsourapas sold 10,000 shares for $920,500 in a recent transaction.

πŸ“‰ Director John T. Cahill sold 4,170 shares for $389,352.90 following the quarter's close.

πŸ›οΈ Institutional ownership stands at 80.41%, with major inflows from California State Teachers Retirement System.

πŸ“Š The stock has a market cap of $71.66 billion and a PE ratio of 35.67.

Bullish Signals
  • Colgate-Palmolive reported quarterly earnings of $0.99 per share, exceeding the consensus estimate of $0.95.
  • Revenue increased by 4.9% year-over-year to reach $5.36 billion in the most recent quarter.
  • The company maintains a consensus 'Moderate Buy' recommendation from nineteen brokerages covering the stock.
  • Piper Sandler lifted its price target to $96.00 and assigned an 'overweight' rating to the shares.
  • Deutsche Bank restated a 'buy' rating and set a price target of $101.00 on the company's stock.
  • The firm offers a 2.4% dividend yield with an annualized payout of $2.12 per share.
Risk Factors
  • The company's dividend payout ratio is relatively high at 84.13%, suggesting limited room for dividend growth.
  • COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction worth $920,500.
  • Director John T. Cahill sold 4,170 shares of the firm's stock for a total value of $389,352.90.
  • JPMorgan Chase dropped its price target on Colgate-Palmolive from $104.00 to $103.00.
Full Analysis
Colgate-Palmolive (NYSE:CL) recently reported quarterly earnings that exceeded analyst expectations, with EPS of $0.99 beating the consensus estimate of $0.95. Revenue reached $5.36 billion, representing a 4.9% year-over-year increase. The company maintains a consensus recommendation of 'Moderate Buy' from nineteen brokerages, with twelve issuing buy ratings and seven holding steady. Wall Street analysts have recently adjusted their price targets for the stock. Piper Sandler lifted its target to $96.00 with an 'overweight' rating, while Deutsche Bank set a target of $101.00. Conversely, JPMorgan Chase lowered its target from $104.00 to $103.00, and TD Cowen raised its target to $90.00 but maintained a 'hold' rating. The average 12-month price target among covering analysts is approximately $99. The company offers an income-focused profile with a quarterly dividend of $0.53 per share, equating to a $2.12 annualized payout and a 2.4% yield. However, the payout ratio is noted as relatively high at 84.13%. Recent insider activity includes significant sales by COO Panagiotis Tsourapas and Director John T. Cahill, with over $16 million in shares sold by insiders in the last 90 days. Institutional ownership remains strong at 80.41%, driven by major inflows from entities like California State Teachers Retirement System and Bank of New York Mellon Corp. The stock currently trades around $89.89, with a market capitalization of $71.66 billion and a PE ratio of 35.67.